JP2023519362A5 - - Google Patents
Info
- Publication number
- JP2023519362A5 JP2023519362A5 JP2022558347A JP2022558347A JP2023519362A5 JP 2023519362 A5 JP2023519362 A5 JP 2023519362A5 JP 2022558347 A JP2022558347 A JP 2022558347A JP 2022558347 A JP2022558347 A JP 2022558347A JP 2023519362 A5 JP2023519362 A5 JP 2023519362A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- amino
- triazolo
- pyrimidine
- pyridyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062994908P | 2020-03-26 | 2020-03-26 | |
| US62/994,908 | 2020-03-26 | ||
| PCT/EP2021/057806 WO2021191378A1 (en) | 2020-03-26 | 2021-03-25 | 5-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one compounds for use against cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023519362A JP2023519362A (ja) | 2023-05-10 |
| JP2023519362A5 true JP2023519362A5 (enExample) | 2024-04-01 |
| JP7675094B2 JP7675094B2 (ja) | 2025-05-12 |
Family
ID=75339740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022558347A Active JP7675094B2 (ja) | 2020-03-26 | 2021-03-25 | トリアゾロン化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230271964A1 (enExample) |
| EP (1) | EP4126872A1 (enExample) |
| JP (1) | JP7675094B2 (enExample) |
| KR (1) | KR20230049579A (enExample) |
| CN (1) | CN115867282B (enExample) |
| AU (1) | AU2021240344A1 (enExample) |
| CA (1) | CA3176944A1 (enExample) |
| WO (1) | WO2021191378A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20241731A1 (es) * | 2022-02-01 | 2024-08-19 | Lilly Co Eli | Procesos para la preparacion de degradadores selectivos del receptor de estrogeno |
| AU2023252914A1 (en) | 2022-04-13 | 2024-10-17 | Arcus Biosciences, Inc. | Combination therapy for treating trop-2 expressing cancers |
| US20250230168A1 (en) | 2023-12-22 | 2025-07-17 | Gilead Sciences, Inc. | Azaspiro wrn inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7452892B2 (en) | 2005-06-17 | 2008-11-18 | Bristol-Myers Squibb Company | Triazolopyrimidine cannabinoid receptor 1 antagonists |
| EP2038285B1 (en) | 2006-06-26 | 2010-02-17 | Schering Corporation | Adenosine a2a receptor antagonists |
| JP2011513417A (ja) * | 2008-03-04 | 2011-04-28 | シェーリング コーポレイション | アデノシンＡ２ａ受容体アンタゴニストとして使用するための１，２，４−トリアゾロ［４，３−ｃ］ピリミジン−３−オンおよびピラゾロ［４，３−ｅ］−１，２，４−トリアゾロ［４，３−ｃ］ピリミジン−３−オン化合物 |
| CN103261202B (zh) | 2010-09-24 | 2016-01-20 | 阿迪维纳斯疗法有限公司 | 作为腺苷受体拮抗剂的稠合三环化合物 |
| EA201792205A1 (ru) | 2015-04-03 | 2018-02-28 | Инсайт Корпорейшн | Гетероциклические соединения как ингибиторы lsd1 |
| KR20190129851A (ko) | 2017-03-16 | 2019-11-20 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | 헤테로아릴[4,3-c]피리미딘-5-아민 유도체, 이의 제조 방법 및 이의 의학적 용도 |
-
2021
- 2021-03-25 WO PCT/EP2021/057806 patent/WO2021191378A1/en not_active Ceased
- 2021-03-25 EP EP21715861.7A patent/EP4126872A1/en active Pending
- 2021-03-25 AU AU2021240344A patent/AU2021240344A1/en active Pending
- 2021-03-25 JP JP2022558347A patent/JP7675094B2/ja active Active
- 2021-03-25 KR KR1020227037221A patent/KR20230049579A/ko not_active Ceased
- 2021-03-25 US US17/914,245 patent/US20230271964A1/en not_active Abandoned
- 2021-03-25 CA CA3176944A patent/CA3176944A1/en active Pending
- 2021-03-25 CN CN202180038001.3A patent/CN115867282B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12247027B2 (en) | P2X7 modulators | |
| ES2373688T3 (es) | Pirrolo[2,3-b]piridinas y pirrolo[2,3-b]pirimidinas sustituidas con heteroarilo como inhibidores de quinasas janus. | |
| JP7860103B2 (ja) | 複素環式スピロ化合物及びその使用方法 | |
| JP5581390B2 (ja) | Ａｋｔ阻害剤 | |
| FI3932919T3 (fi) | Jak-inhibiittoriyhdiste ja sen käyttö | |
| WO2017087905A1 (en) | Compound, compositions, and methods | |
| US12263171B2 (en) | 7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use | |
| JP2024505652A (ja) | Ｃｂｌ－ｂ阻害剤としてのラクタム | |
| JP2019504821A5 (enExample) | ||
| RU2018123779A (ru) | Новые соединения | |
| JP2019517548A5 (enExample) | ||
| WO2016210037A1 (en) | Heteroaryl substituted aminopyridine compounds | |
| JP2013523884A5 (enExample) | ||
| JP2022500402A5 (enExample) | ||
| EP3697410B1 (en) | Benzimidazole derivatives and their uses | |
| CN115697991A (zh) | 哌嗪环状脲 | |
| JP2023539985A5 (enExample) | ||
| JP7681116B2 (ja) | カルボニル置換ジアザスピロ化合物及びその使用 | |
| US20250326753A1 (en) | Dual cxcr4-btk inhibitors | |
| US20220340544A1 (en) | Substituted heterocyclic derivatives as pi3k inhibitors | |
| JP7675094B2 (ja) | トリアゾロン化合物 | |
| JP2023519363A5 (enExample) | ||
| WO2026080794A1 (en) | Chemical compounds useful for degrading proteins | |
| HK40032254A (en) | Benzimidazole derivatives and their uses | |
| KR20160045819A (ko) | 알킨일 알코올 및 이용 방법 |